SEPN - Septerna Inc
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$50.40
DETAILS
HIGH:
$60.00
LOW:
$43.00
MEDIAN:
$49.00
CONSENSUS:
$50.40
UPSIDE:
31.35%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 46,483 | $1.6M | 0.0% | +46,483 | NEW |
| Greenblatt | 9,322 | $312,194 | 0.0% | +9,322 | NEW |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-09-08 | Patni Rajiv | officer: Chief Medical Officer | A-Award | 275,000 | $37.37 | $10.3M |
| 2026-08-24 | Patni Rajiv | ? | -- | -- | -- | |
| 2026-09-01 | Long Daniel D. | officer: SVP, Drug Discovery | SELL | 3,333 | $37.83 | $126K |
| 2026-09-01 | Long Daniel D. | officer: SVP, Drug Discovery | M-Exempt | 3,333 | $2.76 | $9K |
| 2026-08-12 | Third Rock Ventures V, L.P. | 10 percent owner | SELL | 141 | $51.08 | $7K |
| 2026-08-12 | Third Rock Ventures V, L.P. | 10 percent owner | SELL | 147,059 | $50.27 | $7.4M |
| 2026-08-12 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | SELL | 746,500 | $42.50 | $31.7M |
| 2026-08-11 | Bhatt Elizabeth | officer: President and COO | SELL | 25,000 | $44.00 | $1.1M |
| 2026-08-11 | Bhatt Elizabeth | officer: President and COO | M-Exempt | 6,319 | $2.76 | $17K |
| 2026-08-11 | Bhatt Elizabeth | officer: President and COO | M-Exempt | 18,681 | $6.81 | $127K |
| 2026-08-03 | Long Daniel D. | officer: SVP, Drug Discovery | SELL | 1,000 | $33.98 | $34K |
| 2026-08-03 | Long Daniel D. | officer: SVP, Drug Discovery | SELL | 2,334 | $34.68 | $81K |
| 2026-08-03 | Long Daniel D. | officer: SVP, Drug Discovery | M-Exempt | 1,518 | $2.76 | $4K |
| 2026-08-03 | Long Daniel D. | officer: SVP, Drug Discovery | M-Exempt | 1,816 | $2.76 | $5K |
| 2026-07-15 | Bhatt Elizabeth | officer: President and COO | SELL | 4,000 | $33.99 | $136K |
| 2026-07-15 | Bhatt Elizabeth | officer: President and COO | M-Exempt | 4,000 | $6.81 | $27K |
| 2026-07-01 | Long Daniel D. | officer: SVP, Drug Discovery | M-Exempt | 3,333 | $2.76 | $9K |
| 2026-07-01 | Long Daniel D. | officer: SVP, Drug Discovery | SELL | 1,233 | $34.81 | $43K |
| 2026-07-01 | Long Daniel D. | officer: SVP, Drug Discovery | SELL | 2,100 | $34.10 | $72K |
| 2026-06-29 | Shaikhly Samira | officer: Chief People Officer | M-Exempt | 2,178 | $6.81 | $15K |
| 2026-06-29 | Shaikhly Samira | officer: Chief People Officer | SELL | 2,178 | $35.18 | $77K |
| 2026-06-26 | Bassan Abraham | director | A-Award | 15,000 | $37.34 | $560K |
| 2026-06-26 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | A-Award | 15,000 | $37.34 | $560K |
| 2026-06-26 | Sharp Shalini | director | A-Award | 15,000 | $37.34 | $560K |
| 2026-06-26 | Coulie Bernard | director | A-Award | 15,000 | $37.34 | $560K |